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Background: Mitral Regurgitation (MR) on patients undergoing Transcatheter
Aortic Valve Replacement (TAVR) is often left untreated. Whether or not baseline
MR is independently associated with poor outcome remains controversial.
Methods: Patient data from a single center registry was grouped according to the
baseline echocardiogram into those without MR (NoMR) or those with any degree of
MR (MR). We compared the in-hospital outcome, 30 days and 1-year all-cause
mortality. The 1-year adjusted mortality was derived from Cox regression analysis
modeling for the baseline and procedural covariates.
Results: A total of 339 aortic stenosis patients underwent TAVR. MR was present in
25% of the patients and graded as follows: mild: 27%; moderate: 37%; moderate-
severe: 5%; and severe: 1%. At baseline, the prevalence of left ventricular ejection
fraction  40% (36% vs. 17%), systolic pulmonary artery pressure (54  16 vs. 46 
14 mm Hg) and the mean STS score (11.9  5.3 vs. 10.3  4.4) were higher in MR
compared to NoMR group (p<0.05 for all). Transfemoral access was the most
frequent approach in both groups (MR¼ 74% vs. NoMR¼68%; p¼0.29). Patients
with MR had higher rates of hospital complications including mortality compared to
NoMR (Table). However, the 30 day and 1 year mortality were not statistically
different (10.6% vs. 7.9%; p¼0.4) and (27.1% vs. 19.3%; p¼0.1), respectively. In
addition, MR was not associated with adjusted mortality at one year (HR: 1.0 con-
ﬁdence interval 95%: [0.5-1.8]).
Conclusions: Although MR patients undergoing TAVR have a higher frequency of
procedural and in hospital complications compared to those with NoMR, it is not
independently associated to 1-year mortality. Baseline concomitant MR on TVAR
patients may not be in the causal pathway for 1-year mortality and should be left
untreated.VALVE & STRUCTURAL HEART-Valve & Structural Heart
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Background: In patients with hypertrophic cardiomyopathy myocardial ﬁbrosis is an
independent predictor of adverse outcome. A new technique of HOCM surgical
correction in patients with extreme hypertrophy and septal myocardial ﬁbrosis has been
proposed.
Methods: The excision of the asymmetrical hypertrophied area of the inter-
ventricular septum (IVS) causing obstruction was performed from the conal part
of the right ventricle corresponding to the zone of obstruction of the left
ventricle (LV). This excision was carried out on the right side of the IVS and
not trough the whole IVS thickness. The areas of septal myocardial ﬁbrosis were
removed corresponding to the zone of delayed enhancement (DE) imaging.
Myocardial ﬁbrosis was detected by cardiovascular magnetic resonance (with DE
imaging). Nine HOCM patients with extreme hypertrophy (NYHA Class 3,1),
myocardial ﬁbrosis and episodes of ventricular tachycardia (VT) underwent this
procedure. Five patients had biventricular obstruction. The follow-up period was
399 months.
Results: Seven patients were free of symptoms (NYHA class 1) and two patients had
only mild limitations. The mean echocardiographic gradient in LV decreased from
89,92,6 to 9,12,2 mmHg, the mean value of gradient in right ventricular outﬂow
tract was reduced from 43,45,2 to 4,31,3 mmHg. Echocardiographically deter-
mined septal thickness was reduced from 34,73,1 to 15,62,1mm. Sinus rhythm
without block of His bundle right branch was noted in all patients after surgery. VT
was not registered. None of the patients needed implantation of cardioverter-
deﬁbrillator.
Conclusion: This novel technique of HOCM surgical correction provides the precise
removal of the areas of septal ﬁbrosis and effective elimination of biventricular
obstruction in patients with extreme hypertrophy who cannot be treated with the
current surgical techniques. The approach avoids mechanical damage to the heart
conduction system.
